ICU MedicalICUI
Market Cap: $3.96B
About: ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.
Employees: 14,000
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
31% more repeat investments, than reductions
Existing positions increased: 98 | Existing positions reduced: 75
14% more capital invested
Capital invested by funds: $2.47B [Q1] → $2.81B (+$349M) [Q2]
13% more first-time investments, than exits
New positions opened: 44 | Existing positions closed: 39
2.13% more ownership
Funds ownership: 95.12% [Q1] → 97.25% (+2.13%) [Q2]
2% more funds holding
Funds holding: 249 [Q1] → 254 (+5) [Q2]
20% less call options, than puts
Call options by funds: $3.38M | Put options by funds: $4.22M
Research analyst outlook
3 Wall Street Analysts provided 1 year price targets over the past 3 months
3 analyst ratings
Keybanc Brett Fishbin 87% 1-year accuracy 13 / 15 met price target | 9%downside $147 | Overweight Maintained | 8 Aug 2024 |
Raymond James Jayson Bedford 73% 1-year accuracy 22 / 30 met price target | 3%downside $158 | Outperform Maintained | 8 Aug 2024 |
Raymond James Jayson Bedford 73% 1-year accuracy 22 / 30 met price target | 17%downside $135 | Outperform Upgraded | 17 Jun 2024 |
Financial journalist opinion
Based on 3 articles about ICUI published over the past 30 days